Abstract

Peptides corresponding to residues 65-79 of human lymphocyte antigen class II sequence (DQA*03011) are cell-permeable and at high concentrations block activation of protein kinase B/Akt and p70-S6 kinase in T-cells, effects attributed to inhibition of phosphoinositide (PI) 3-kinase activity. To understand the molecular basis of this, we analyzed the effect this peptide had on activity of class I PI 3-kinases. Although there was no effect on the activity of class Ib PI 3-kinase or on the protein kinase activity of class I PI 3-kinases, there was a biphasic effect on lipid kinase activity of the class Ia enzymes. There was an inhibition of activity at higher peptide concentrations because of a formation of insoluble complexes between peptide and enzyme. Conversely, at lower peptide concentrations there was a profound activation of PI 3-kinase activity of class Ia PI 3-kinases. Studies of peptide variants revealed that all active peptides conform to heptad repeat motifs characteristic of coiled-coil helices. Surface plasmon resonance studies confirmed direct sequence-specific binding of active peptide to the p85alpha adapter subunit of class Ia PI 3-kinase. Active peptides also activated protein kinase B and extracellular signal-regulated kinase (ERK) in vivo in a wortmannin-sensitive manner while reducing recoverable cellular p85 levels. These results indicate that the human lymphocyte antigen class II-derived peptides regulate PI 3-kinase by direct interaction, probably via the coiled-coil domain. These peptides define a novel mechanism of regulating PI 3-kinase and will provide a useful tool for specifically dissecting the function of class Ia PI 3-kinase in cells and for probing structure-function relationships in the class Ia PI 3-kinase heterodimers.

Highlights

  • Phosphoinositide (PI)1 3-kinases play a pivotal role in signaling pathways regulating a wide range of cellular processes including apoptosis, metabolism, cell growth, cell proliferation, and cytoskeletal rearrangements [1,2,3]

  • A potentially novel mechanism for regulating PI 3-kinase activity has recently emerged from studies of the properties of biologically active peptides derived from class II MHC molecules [5]

  • The current findings extend previous studies by demonstrating that the inhibition of PI 3-kinase activity induced by MHC class II DQA 65–79 peptide is specific to the class Ia isoforms

Read more

Summary

EXPERIMENTAL PROCEDURES

Polyclonal anti-p110␣-specific antibody was provided by Dr Bart Vanhaesebroeck (Ludwig Institute for Cancer Research, University College London, UK). The peptides were applied to a disposable Sep-Pak C8 reversed-phase cartridge (Waters); washed extensively with 0.01% trifluoroacetic acid, 2% acetonitrile; eluted with 0.01% trifluoroacetic acid, 80% acetonitrile; dried; and resuspended in interaction buffer. They were injected over a sensor chip surface on which avidin (Calbiochem) was immobilized covalently to a level of 3000 resonance units and allowed to reach saturation.

RHNGNIMLDK mTOR
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.